Clinical Trial

Efficacy Of Laser Acupuncture Combined With Physiotherapy In Tennis Elbow Syndrome

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 2, 2024 (before its estimated September 2024 completion). Its status may not reflect the trial's current state.
Summary
Tennis Elbow (TE) syndrome affects 1 to 3% of adults annually. The burden of TE syndrome continues to increase annually due to repeated microtrauma to the forearm extensor tendon. Treatment mainly includes anti-inflammatory pain medications, physical therapy, shockwave therapy, Laser acupuncture therapy, topical nitrates, elbow braces, and corticosteroid injections. Surgery is considered for cases where conservative treatment fails, including open and arthroscopic surgery. Laser acupuncture (LA) is a new acupuncture technique using Laser beams to stimulate acupuncture points, offering a less invasive alternative to traditional needles and demonstrating therapeutic effectiveness. Recent Studies have shown that LA significantly improves pain in TE patients. Additionally, combining physical therapy for functional rehabilitation in treating TE syndrome plays an essential role in alleviating pain and restoring elbow joint function, preventing long-term stiffness. In practice, many hospitals apply a combination of LA and physical therapy to treat TE with considerable effectiveness, though it has not been thoroughly evidence-based. Given the limitations in evaluating treatment effectiveness and the lack of published research discussing the analgesic effects of LA for TE syndrome, as well as to enhance the effectiveness of combining TCM and modern medicine, the investigators conducted the study Pain Reduction and Range of Motion Improvement of LA Combined with Physical Therapy in Patients with TE syndrome.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06535594
Lead Sponsor University of Medicine and Pharmacy at Ho Chi Minh City
Conditions Pain
Enrollment 30 participants
Start Date 2024-08-01
Primary Completion 2024-09 (estimated)
Study Completion 2024-09 (estimated)
Updated on ClinicalTrials.gov 2024-08-02